Gynaemed Vaginal Tablet contains Clotrimazole 100 mg, an imidazole antifungal agent indicated for the treatment of vaginal candidiasis caused by susceptible strains of Candida species. Clotrimazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Gynaemed Vaginal Tablet is administered intravaginally, providing localized antifungal activity with minimal systemic absorption, which reduces the risk of systemic side effects. It is typically prescribed for the management of vulvovaginal candidiasis presenting with symptoms such as itching, burning, discharge, and irritation. The treatment regimen usually involves a single-dose or short-course application, improving patient compliance. Contraindications include hypersensitivity to clotrimazole or any excipients in the formulation. Caution is advised in patients with a history of hypersensitivity reactions to azole antifungals. Common adverse effects may include local irritation, burning sensation, or itching at the site of application. Gynaemed Vaginal Tablet should be used under medical supervision, and patients are advised to complete the full course of treatment even if symptoms resolve earlier to prevent recurrence. It is not recommended for use during the first trimester of pregnancy unless clearly needed and prescribed by a healthcare professional.